Benefit Corporation: a path to affordable gene therapies?
Sign Up to like & getrecommendations! Published in 2019 at "Nature Medicine"
DOI: 10.1038/s41591-019-0676-z
Abstract: With the growing number of efficient gene therapies on the market, now is the time to take actions to ensure reasonable pricing of gene therapy products. Among these, we propose to incentivize gene therapy companies… read more here.
Keywords: corporation path; benefit corporation; affordable gene; gene ... See more keywords